56962-14-2

Basic information

• Product Name: Benzaldehyde, 2,6-dichloro-3-hydroxy-
• CAS NO: 56962-14-2
• Molecular Formula: C7H4Cl2O2
• Molecular Weight: 191.014
• Mol File: 56962-14-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 2,6-dichloro-3-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2,6-dichloro-3-hydroxy-(56962-14-2)
• EPA Substance Registry System: Benzaldehyde, 2,6-dichloro-3-hydroxy-(56962-14-2)

Safety Data

• Hazardous Substances Data: 56962-14-2(Hazardous Substances Data)

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 68-12-2 N,N-dimethyl-formamide 
• 169619-83-4 tert-butyl-(2,4-dichloro-phenoxy)-dimethyl-silane 
• 120-83-2 2,4-dichlorophenol 
• 179626-59-6 2,4-dichlorotriisopropylsilyloxybenzene 

Downstream Products

• 103855-02-3 N,N'-(2,6-dichloro-3-hydroxy-benzylidene)-bis-acetamide 
• 873983-87-0 4-bromo-2,6-dichloro-3-hydroxy-benzaldehyde 
• 120-83-2 2,4-dichlorophenol 
• 5051-54-7 N,N-Dimethyl-N'-(2,6-dichlor-3-hydroxybenzyliden)-hydrazin 
• 1036383-24-0 2,6-dichloro-3-(2,2,2-trifluoro-ethoxy)-benzaldehyde 
• 1439373-61-1 C₁₄H₁₁BrCl₂O 
• 1439373-60-0 C₁₄H₁₂Cl₂O₂ 
• 931410-23-0 3-allyloxy-2,6-dichlorobenzaldehyde 
• 6505-37-9 2,6-dichloro-3-methoxybenzaldehyde 
• 860243-14-7 4-bromo-2,6-dichloro-3-methoxy-benzaldehyde 
• 60633-26-3 1-bromo-3,5-dichloro-2-methoxybenzene 
• 7396-91-0 2,4-dichlorophenyl benzoate 
• 4524-77-0 2-bromo-4,6-dichlorophenol 
• 64-18-6 formic acid 

Relevant articles and documents

Isolation, structure determination and synthesis of a trichlorodihydroxybibenzyl from a terrestrial plant

A new natural product isolated from the leaves of the plant Anthurium aripoense found in Trinidad is shown by spectroscopic analysis and total synthesis to be 2′,5,6′-trichloro-2,3′-dihydroxybibenzyl, a structure unprecedented in a higher plant. The Royal Society of Chemistry 2013.

CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1

The present invention discloses compounds of Formula I: (I) having 11beta -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.

Synthesis and evaluation of the anti-mammary tumor activity and of the estrogenic side effects of platinum(II) complexes

The synthesis and structural characterization of mammary tumor-inhibiting, diastereomeric platinum(II) complexes with 2,6-Cl2, 2F, 6-Cl, 2-Cl, 6-F and 2,6-F2 substituents (1-PtSO4 to 4-PtSO4) are describ